• 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Ayala

CTech 24/7

  • Quantum startup Classiq adds $10M+ to Series C with SoftBank on board
  • CyberArk, not SentinelOne, was always the goal, says Palo Alto CEO
  • Palo Alto CEO on $25B CyberArk deal: “This is the lowest our stock will be for the next five years”
  • CyberArk’s $25B exit enriches global funds, not Israelis
More stories in CTech

Ayala

3 stories about Ayala
  • Nasdaq. Photo: Shutterstock

    Ayala Pharmaceuticals Headed for Nasdaq IPO

    07.01.20|Golan Hazani The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation

  • Cancer (illustration). Photo: Shutterstock

    Ayala Pharmaceuticals Raises $30 Million

    29.05.19|Adi PickThe Israel-based company intends to use the new round of funding to advance the clinical development of its anti-cancer product

  • Cancer (illustration). Photo: Shutterstock

    Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

    24.12.18|Lilach BaumerThe investment is part of a licensing option agreement signed between the two companies

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive